2',5'-二(三氟甲基)苯乙酮 | 545410-47-7

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 2',5'-二(三氟甲基)苯乙酮
• 中文别名: 2’,5’-二(三氟甲基)苯乙酮
• 英文名称: 2,5-bistrifluoromethyl-1-methylcarbonylbenzene
• 英文别名: 2',5'-Bis(trifluoromethyl)acetophenone；1-[2,5-bis(trifluoromethyl)phenyl]ethanone
• CAS: 545410-47-7
• 化学式: C₁₀H₆F₆O
• 分子量: 256.147
• InChiKey: ZBIHDCGAPRWDOA-UHFFFAOYSA-N

物化性质

• 沸点：
  206.1±40.0 °C(Predicted)
• 密度：
  1.362±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  17
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  7

安全信息

• 海关编码：
  2914700090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  室温

反应信息

• 作为反应物：
  描述：

  2',5'-二(三氟甲基)苯乙酮 在 溴 、 溶剂黄146 作用下， 以 乙腈 为溶剂， 生成 2,5-bistrifluoromethyl-1-(imidazol-1-ylmethylcarbonyl)benzene
  参考文献：
  名称：

  N -[1-Aryl-2-(1-imidazolo)ethyl]-guanidine derivatives as potent inhibitors of the bovine mitochondrial F 1 F 0 ATP hydrolase

  摘要：

  A series of substituted guanidine derivatives were prepared and evaluated as potent and selective inhibitors of mitochondrial F1F0 ATP hydrolase. The initial thiourethane derived lead molecules possessed intriguing in vitro pharmacological profiles, though contained moieties considered non-drug-like. Analogue synthesis efforts led to compounds with maintained potency and superior physical properties. Small molecules in this series which potently and selectivity inhibit ATP hydrolase and not ATP synthase may have utility as cardioprotective agents. (C) 2003 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2003.11.077
• 作为产物：
  描述：

  2,5-双(三氟甲基)苯甲酰氯 、 甲基溴化镁 在 三丁基膦 、 盐酸 作用下， 以 四氢呋喃 、 水 为溶剂， 反应 0.94h， 以56%的产率得到2',5'-二(三氟甲基)苯乙酮
  参考文献：
  名称：

  (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial F1F0 ATP hydrolase

  摘要：

  具有化学式（I）的化合物及其药用盐对调节线粒体F1F0ATP酶活性和治疗包括心肌梗死、充血性心力衰竭和心律失常在内的缺血性疾病具有用处。

  公开号：

  US20040039033A1

文献信息

• Novel 1, 2-Disubstituted Amido-anthraquinone Derivatives, Preparation Method and application thereof
  申请人：HUANG Hsu-Shan

  公开号：US20110207739A1

  公开（公告）日：2011-08-25

  A series of novel 1,2-disubstituted amido-anthraquinone derivatives, and the preparation method and application of said derivatives. Said application includes said derivatives with therapeutically effective amount being prepared into pharmaceutical compositions for inhibition of cancer cell growth, further treating cancer.

  一系列新颖的1,2-二取代氨基蒽醌衍生物，以及所述衍生物的制备方法和应用。所述应用包括将所述衍生物与治疗有效量配制成药物组合物，用于抑制癌细胞生长，进一步治疗癌症。
• [EN] PROCESS FOR PRODUCING TRIFLUOROMETHYL-SUBSTITUTED 2-ALKOXYACETOPHENONE DERIVATIVES<br/>[FR] PROCEDE DE PRODUCTION DE DERIVES DE 2-ALCOXYACETOPHENONE TRIFLUOROMETHYLE-SUBSTITUEE
  申请人：CENTRAL GLASS CO LTD

  公开号：WO2004014887A1

  公开（公告）日：2004-02-19

  A process for producing a brominated acetal (represented by the formula 3) includes (a) brominating a trifluoromethyl-substituted acetophenone by Br2 in the presence of an alkylene diol. It is optional to produce a trifluoromethyl-substituted 2-alkoxyacetophenone derivative (represented by the formula 9) by (b) reacting the brominated acetal with a metal alkoxide, thereby converting the brominated acetal into an ether; and (c) hydrolyzing the ether in the presence of an acid catalyst to remove an acetal group from the ether, thereby producing the 2-alkoxyacetophenone derivative. Alternatively, the 2-alkoxyacetophenone can be produced by (a) reacting a trifluoromethyl-substituted phenacyl halide with an acetalization agent, thereby converting the phenacyl halide into an acetal; (b) reacting the acetal with a metal alkoxide, thereby converting the acetal into an ether; and (c) hydrolyzing the ether in the presence of an acid catalyst to remove the acetal group from the ether.

  生产溴代缩醛（化学式3）的过程包括：（a）在烷基二醇存在下，用Br2对三氟甲基取代的乙酰苯甲酮进行溴化。可以通过以下步骤制备三氟甲基取代的2-烷氧基乙酰苯甲酮衍生物（化学式9）：（b）将溴代缩醛与金属烷氧化物反应，将溴代缩醛转化为醚；（c）在酸催化剂存在下水解醚，从而从醚中去除缩醛基，从而制备2-烷氧基乙酰苯甲酮衍生物。或者，可以通过以下步骤制备2-烷氧基乙酰苯甲酮：（a）将三氟甲基取代的苯甲酰卤与缩醛化试剂反应，将苯甲酰卤转化为缩醛；（b）将缩醛与金属烷氧化物反应，将缩醛转化为醚；（c）在酸催化剂存在下水解醚，从而从醚中去除缩醛基。
• Process for producing trifluoromethyl- substituted 2- alkoxyacetophenone derivatives
  申请人：Ishii Akihiro

  公开号：US20050171363A1

  公开（公告）日：2005-08-04

  A process for producing a brominated acetal (represented by the formula 3) includes (a) brominating a trifluoromethyl-substituted acetophenone by Br 2 in the presence of an alkylene diol. It is optional to produce a trifluoromethyl-substituted 2-alkoxyacetophenone derivative (represented by the formula 9) by (b) reacting the brominated acetal with a metal alkoxide, thereby converting the brominated acetal into an ether; and (c) hydrolyzing the ether in the presence of an acid catalyst to remove an acetal group from the ether, thereby producing the 2-alkoxyacetophenone derivative. Alternatively, the 2-alkoxyacetophenone can be produced by (a) reacting a trifluoromethyl-substituted phenacyl halide with an acetalization agent, thereby converting the phenacyl halide into an acetal; (b) reacting the acetal with a metal alkoxide, thereby converting the acetal into an ether; and (c) hydrolyzing the ether in the presence of an acid catalyst to remove the acetal group from the ether.

  生产溴化缩醛（由式 3 表示）的工艺包括 (a) 用 Br 2 溴化三氟甲基取代的苯乙酮。可选择通过以下方法生产三氟甲基取代的 2-烷氧基苯乙酮衍生物（由式 9 表示）：(b) 使溴化缩醛与金属氧化烷反应，从而将溴化缩醛转化为醚；(c) 在酸催化剂存在下水解醚，从醚中除去缩醛基团，从而生产 2-烷氧基苯乙酮衍生物。或者，2-烷氧基苯乙酮可以通过以下方法制得：(a) 使三氟甲基取代的苯酰卤与缩醛剂反应，从而将苯酰卤转化为缩醛；(b) 使缩醛与金属烷氧基反应，从而将缩醛转化为醚；(c) 在酸催化剂存在下水解醚，以除去醚中的缩醛基团。
• DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
  申请人：Merck & Co., Inc.

  公开号：EP1385508B1

  公开（公告）日：2008-05-21
• (1-PHENYL-2-HETEROARYL)ETHYL-GUANIDINE COMPOUNDS AS INHIBITORS OF MITOCHONDRIAL F1F0 ATP HYDROLASE
  申请人：Bristol-Myers Squibb Company

  公开号：EP1450901A2

  公开（公告）日：2004-09-01